Entity Details

Primary name STAT4
Entity type gene
Source Source Link

Details

PrimaryID6775
RefseqGeneNG_012852
SymbolSTAT4
Namesignal transducer and activator of transcription 4
Chromosome2
Location2q32.2-q32.3
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1997-09-23
ModificationDate2021-06-13

Ontological Relatives

UniProt IDsSTAT4_HUMAN

GO terms

Show/Hide Table
GOName
GO:0000785 chromatin
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
GO:0003700 DNA-binding transcription factor activity
GO:0005654 nucleoplasm
GO:0005829 cytosol
GO:0006357 regulation of transcription by RNA polymerase II
GO:0006952 defense response
GO:0007259 receptor signaling pathway via JAK-STAT
GO:0019221 cytokine-mediated signaling pathway
GO:0035722 interleukin-12-mediated signaling pathway
GO:0038114 interleukin-21-mediated signaling pathway
GO:0038155 interleukin-23-mediated signaling pathway
GO:0042127 regulation of cell population proliferation
GO:0042802 identical protein binding
GO:0043434 response to peptide hormone
GO:0045944 positive regulation of transcription by RNA polymerase II
GO:0070757 interleukin-35-mediated signaling pathway

Diseases

Show/Hide Table
Disease IDSourceNameDescription
180300 OMIMRheumatoid arthritis (RA)An inflammatory disease with autoimmune features and a complex genetic component. It primarily affects the joints and is characterized by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Disease susceptibility is associated with variants affecting the gene represented in this entry.
612253 OMIMSystemic lupus erythematosus 11 (SLEB11)A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Disease susceptibility is associated with variants affecting the gene represented in this entry.